The findings of many studies have confirmed that the serum concentrations of PAPP-A are decreased at 11 to 14 weeks of gestation in women who develop hypertensive disorders during pregnancy, and it is more evident in those pregnant women who have early-onset PE. Here, PAPPA is linked to hypertensive disorder.